Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
Adherence to Current Vaccination Recommendations for Patients With Rheumatoid Arthritis in Mexico
Andrea Sofia Cepeda-Perez1, Nina Tello Winniczuk2, Alejandro Diaz-Borjon2
1Reumatología, Instituto Nacional de Rehabilitación, Ciudad de México, México.
Background:
Patients with RA have a two to four-fold increased risk of developing infections compared to the general population. For this reason, the administration of influenza, pneumococcal and shingles vaccines is recommended for all patients with RA, preferably prior to initiating treatment, Previous studies have demonstrated the low prevalence of vaccination as well as adherence to current recommendations by rheumatologists in other regions.
Objective:
To determine the knowledge and adherence to the current vaccination recommendations for patients with RA by rheumatology members of the Mexican College of Rheumatology (MCR), and to identify barriers to their application in this population.
Methods:
A cross-sectional study was conducted through a survey sent to 577 rheumatologists from Mexico in January 2017.
Results:
We received completed surveys from 122 individuals, representing 21.14% of the 577 rheumatologists in our registry. Fifty percent responded that they recommended immunization against influenza to 76%-100% of their patients, 36.07% recommended immunization against pneumococcus to 76%-100% of their patients, and 69.67% of the survey responders did not recommend shingles immunization routinely to their patients.
Conclusions:
The data collected in this study show there is poor adherence to immunization schedules recommended for the RA population. This data suggests there is misinformation about the effectiveness, safety and optimal timing of immunization in patients with RA in Mexico.
Insights
Rheumatologists in Mexico show poor adherence to recommended vaccination schedules for rheumatoid arthritis (RA) patients. This highlights potential misinformation regarding vaccine effectiveness, safety, and timing in this population.
Area of Science:
- Rheumatology
- Infectious Diseases
- Public Health
Background:
- Patients with rheumatoid arthritis (RA) face a significantly higher risk of infections.
- Vaccination against influenza, pneumococcal disease, and shingles is recommended for RA patients, ideally before treatment initiation.
- Prior studies indicate low vaccination rates and poor adherence to recommendations among rheumatologists globally.
Purpose of the Study:
- To assess rheumatologists' knowledge and adherence to vaccination guidelines for RA patients in Mexico.
- To identify barriers preventing the implementation of vaccination recommendations in this patient group.
Main Methods:
- A cross-sectional survey was distributed to 577 rheumatologists affiliated with the Mexican College of Rheumatology (MCR).
- Data collection occurred in January 2017, with a response rate of 21.14% (122 completed surveys).
Main Results:
- Only 50% of surveyed rheumatologists routinely recommended influenza immunization to most of their RA patients.
- Vaccination against pneumococcal disease was recommended by 36.07% of respondents for the majority of patients.
- A significant majority (69.67%) did not routinely recommend shingles immunization to their RA patients.
Conclusions:
- The study reveals inadequate adherence to recommended immunization schedules for patients with RA in Mexico.
- Findings suggest a potential gap in understanding or awareness regarding the efficacy, safety, and optimal timing of vaccinations for RA patients.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Electrical Current
Significance of Displacement Current
Current Trends in Nursing I
Current Trends in Nursing II

